These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38269489)

  • 1. Variable domain mutational analysis to probe the molecular mechanisms of high viscosity of an IgG
    Dai J; Izadi S; Zarzar J; Wu P; Oh A; Carter PJ
    MAbs; 2024; 16(1):2304282. PubMed ID: 38269489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in human IgG1 and IgG4 S228P monoclonal antibodies viscosity and self-interactions: Experimental assessment and computational predictions of domain interactions.
    Lai PK; Ghag G; Yu Y; Juan V; Fayadat-Dilman L; Trout BL
    MAbs; 2021; 13(1):1991256. PubMed ID: 34747330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.
    Nichols P; Li L; Kumar S; Buck PM; Singh SK; Goswami S; Balthazor B; Conley TR; Sek D; Allen MJ
    MAbs; 2015; 7(1):212-30. PubMed ID: 25559441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
    MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissecting the molecular basis of high viscosity of monospecific and bispecific IgG antibodies.
    Tilegenova C; Izadi S; Yin J; Huang CS; Wu J; Ellerman D; Hymowitz SG; Walters B; Salisbury C; Carter PJ
    MAbs; 2020; 12(1):1692764. PubMed ID: 31779513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of the high concentration viscosity of IgG
    Heisler J; Kovner D; Izadi S; Zarzar J; Carter PJ
    MAbs; 2024; 16(1):2379560. PubMed ID: 39028186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subclass Effects on Self-Association and Viscosity of Monoclonal Antibodies at High Concentrations.
    Chowdhury AA; Manohar N; Witek MA; Woldeyes MA; Majumdar R; Qian KK; Kimball WD; Xu S; Lanzaro A; Truskett TM; Johnston KP
    Mol Pharm; 2023 Jun; 20(6):2991-3008. PubMed ID: 37191356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Charge-mediated Fab-Fc interactions in an IgG1 antibody induce reversible self-association, cluster formation, and elevated viscosity.
    Arora J; Hu Y; Esfandiary R; Sathish HA; Bishop SM; Joshi SB; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2016; 8(8):1561-1574. PubMed ID: 27560842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the High Viscosity of a Therapeutic Monoclonal Antibody in High Concentration Formulations by Microdialysis-Hydrogen/Deuterium Exchange Mass Spectrometry.
    Xu X; Zhang A; Xu Y; Cao Y; Cale S; Franklin M; Sarangapani P; Ihnat PM; Qiu H; Liu D; Pyles EA; Shameem M; Li N
    J Pharm Sci; 2022 May; 111(5):1335-1345. PubMed ID: 34999091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of therapeutic antibody self-association using yeast-display selections and machine learning.
    Makowski EK; Chen H; Lambert M; Bennett EM; Eschmann NS; Zhang Y; Zupancic JM; Desai AA; Smith MD; Lou W; Fernando A; Tully T; Gallo CJ; Lin L; Tessier PM
    MAbs; 2022; 14(1):2146629. PubMed ID: 36433737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developability Assessment of Engineered Monoclonal Antibody Variants with a Complex Self-Association Behavior Using Complementary Analytical and in Silico Tools.
    Shan L; Mody N; Sormani P; Rosenthal KL; Damschroder MM; Esfandiary R
    Mol Pharm; 2018 Dec; 15(12):5697-5710. PubMed ID: 30395473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineering.
    Geoghegan JC; Fleming R; Damschroder M; Bishop SM; Sathish HA; Esfandiary R
    MAbs; 2016 Jul; 8(5):941-50. PubMed ID: 27050875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterizing Protein-Protein Interactions and Viscosity of a Monoclonal Antibody from Low to High Concentration Using Small-Angle X-ray Scattering and Molecular Dynamics Simulations.
    Chowdhury AA; Manohar N; Lanzaro A; Kimball WD; Witek MA; Woldeyes MA; Majumdar R; Qian KK; Xu S; Gillilan RE; Huang Q; Truskett TM; Johnston KP
    Mol Pharm; 2023 Nov; 20(11):5563-5578. PubMed ID: 37782765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of the Viscosity of an Antibody Solution from the Diffusion Interaction Parameter.
    Shimomura T; Sekiguchi M; Honda R; Yamazaki M; Yokoyama M; Uchiyama S
    Biol Pharm Bull; 2022; 45(9):1300-1305. PubMed ID: 36047198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular computations of preferential interactions of proline, arginine.HCl, and NaCl with IgG1 antibodies and their impact on aggregation and viscosity.
    Cloutier TK; Sudrik C; Mody N; Hasige SA; Trout BL
    MAbs; 2020; 12(1):1816312. PubMed ID: 32938318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Machine learning prediction of antibody aggregation and viscosity for high concentration formulation development of protein therapeutics.
    Lai PK; Gallegos A; Mody N; Sathish HA; Trout BL
    MAbs; 2022; 14(1):2026208. PubMed ID: 35075980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity.
    Cloutier T; Sudrik C; Mody N; Sathish HA; Trout BL
    Mol Pharm; 2019 Aug; 16(8):3657-3664. PubMed ID: 31276620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of monoclonal antibody viscosity using interpretable machine learning.
    Makowski EK; Chen HT; Wang T; Wu L; Huang J; Mock M; Underhill P; Pelegri-O'Day E; Maglalang E; Winters D; Tessier PM
    MAbs; 2024; 16(1):2303781. PubMed ID: 38475982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homology modeling and structure-based design improve hydrophobic interaction chromatography behavior of integrin binding antibodies.
    Jetha A; Thorsteinson N; Jmeian Y; Jeganathan A; Giblin P; Fransson J
    MAbs; 2018; 10(6):890-900. PubMed ID: 30110240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.